Skip to main content
Equibles

Sekar Kathiresan, M.D.

Board Member

Relay Therapeutics, Inc. (RLAY)

Equibles does not estimate personal net worth.

Get an email with a short summary when Relay Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get RLAY alerts

About Sekar Kathiresan, M.D.

Sekar Kathiresan, M.D. is recorded as Board Member at Relay Therapeutics, Inc. (RLAY) since July 25, 2022. Relay Therapeutics, Inc. reported in an 8-K filed July 27, 2022 that Sekar Kathiresan, M.D. was appointed class III director, effective July 25, 2022. Relay Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Relay Therapeutics, Inc. includes Thomas Catinazzo (CFO), Brian R. Adams (General Counsel), Claire Mazumdar (Board Member) and 3 others.

“On July 25, 2022, the board of directors (the “Board”) of Relay Therapeutics, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Sekar Kathiresan, M.D. to the Board as a class III director to fill the newly created vacancy on the Board resulting from an increase in the size of the Board from seven (7) to eight (8) directors.”
Relay Therapeutics, Inc. Form 8-K, filed July 27, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Relay Therapeutics, Inc.

Recent activity